Joel A Sincavage

Array ( [id] => 6678477 [patent_doc_number] => 20030228618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same' [patent_app_type] => new [patent_app_number] => 10/441281 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 31080 [patent_no_of_claims] => 113 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228618.pdf [firstpage_image] =>[orig_patent_app_number] => 10441281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075260 [patent_doc_number] => 20050148528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Method for reducing platelet count' [patent_app_type] => utility [patent_app_number] => 10/514970 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3461 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148528.pdf [firstpage_image] =>[orig_patent_app_number] => 10514970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269836 [patent_doc_number] => 20040058354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Mammalian alpha-helical protein-53' [patent_app_type] => new [patent_app_number] => 10/416860 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18269 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058354.pdf [firstpage_image] =>[orig_patent_app_number] => 10416860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7318966 [patent_doc_number] => 20040224912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Modulation of PAI-1 mRNA-binding protein expression' [patent_app_type] => new [patent_app_number] => 10/434350 [patent_app_country] => US [patent_app_date] => 2003-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20522 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224912.pdf [firstpage_image] =>[orig_patent_app_number] => 10434350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743597 [patent_doc_number] => 20060089322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Antisense oligonucleotides for identifying drug targets and enhancing cancer therapies' [patent_app_type] => utility [patent_app_number] => 10/513255 [patent_app_country] => US [patent_app_date] => 2003-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14086 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089322.pdf [firstpage_image] =>[orig_patent_app_number] => 10513255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701552 [patent_doc_number] => 20030224432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Methods and compositions for use in preparing siRNAs' [patent_app_type] => new [patent_app_number] => 10/427758 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17278 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224432.pdf [firstpage_image] =>[orig_patent_app_number] => 10427758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777333 [patent_doc_number] => 20060105973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression' [patent_app_type] => utility [patent_app_number] => 10/511832 [patent_app_country] => US [patent_app_date] => 2003-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29852 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105973.pdf [firstpage_image] =>[orig_patent_app_number] => 10511832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649715 [patent_doc_number] => 20060135450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Combinations of antisense oligonucleotides directed against thymidylate synthase mrna and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/510899 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16779 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135450.pdf [firstpage_image] =>[orig_patent_app_number] => 10510899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 606583 [patent_doc_number] => 07153948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-26 [patent_title] => 'High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)' [patent_app_type] => utility [patent_app_number] => 10/409565 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 31 [patent_no_of_words] => 9460 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153948.pdf [firstpage_image] =>[orig_patent_app_number] => 10409565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467849 [patent_doc_number] => 20040053872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'New sequences' [patent_app_type] => new [patent_app_number] => 10/362676 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10352 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053872.pdf [firstpage_image] =>[orig_patent_app_number] => 10362676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395631 [patent_doc_number] => 20040022772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth' [patent_app_type] => new [patent_app_number] => 10/397062 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 27796 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022772.pdf [firstpage_image] =>[orig_patent_app_number] => 10397062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7441954 [patent_doc_number] => 20040185559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Modulation of diacylglycerol acyltransferase 1 expression' [patent_app_type] => new [patent_app_number] => 10/394808 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21938 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185559.pdf [firstpage_image] =>[orig_patent_app_number] => 10394808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6836294 [patent_doc_number] => 20030163840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Replication protein A and use' [patent_app_type] => new [patent_app_number] => 10/371558 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19089 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20030163840.pdf [firstpage_image] =>[orig_patent_app_number] => 10371558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470583 [patent_doc_number] => 20040096843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules' [patent_app_type] => new [patent_app_number] => 10/365643 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7721 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096843.pdf [firstpage_image] =>[orig_patent_app_number] => 10365643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743596 [patent_doc_number] => 20060089321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Cks1 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/504487 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23554 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089321.pdf [firstpage_image] =>[orig_patent_app_number] => 10504487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6648788 [patent_doc_number] => 20030213012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Pesticidal agents' [patent_app_type] => new [patent_app_number] => 10/365319 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6110 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20030213012.pdf [firstpage_image] =>[orig_patent_app_number] => 10365319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 369885 [patent_doc_number] => 07476658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Conjugate for treating prokaryotic infections' [patent_app_type] => utility [patent_app_number] => 10/501962 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 11 [patent_no_of_words] => 3882 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476658.pdf [firstpage_image] =>[orig_patent_app_number] => 10501962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805383 [patent_doc_number] => 20030232777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Phosphatidylinositol-4-phosphate 5-kinase, type II beta inhibitors for inhibiting angiogenesis' [patent_app_type] => new [patent_app_number] => 10/348073 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32810 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232777.pdf [firstpage_image] =>[orig_patent_app_number] => 10348073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835164 [patent_doc_number] => 20030162710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Physiologically active polypeptide and DNA' [patent_app_type] => new [patent_app_number] => 10/335847 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5708 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162710.pdf [firstpage_image] =>[orig_patent_app_number] => 10335847 [rel_patent_id] =>[rel_patent_doc_number] =>)